Marinomed Biotech AG | WebDisclosure

Basculer en Français

10069	Companies
205847	Keywords
136110	Articles
109148	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 06/14/2024 at 07:45, 1 year 9 months ago

Marinomed Biotech AG secures licensure with leading Consumer Health Care player for the distribution of Carragelose® products in Europe
Marinomed Biotech AG expands licensing agreement with leading Consumer Health Care player for Carragelose® product distribution in Europe, enabling milestone payments

Marinomed Biotech AG Distribution Carragelose® Consumer Health Care Licensure
BRIEF

published on 05/22/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG Reports Q1 2024 Financial Results

Financial Performance Biotech Partnerships Q1 2024 Results Marinomed
BRIEF

published on 05/22/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG publie ses résultats financiers du premier trimestre 2024

Performance Financière Partenariats Marinomé Résultats Du Premier Trimestre 2024 Biotechnologies
PRESS RELEASE

published on 05/22/2024 at 07:45, 1 year 10 months ago

Marinomed Biotech AG announces results for the first quarter of 2024
Marinomed Biotech AG announces results for Q1 2024 with declining revenues to pre-pandemic levels. New partnerships, agreements, and initiatives in place to boost cash flows and cover financing needs

Partnerships Marinomed Biotech AG Q1 2024 Results Revenues Decline Cash Flow Initiatives
BRIEF

published on 04/25/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG Announces New R&D Collaboration with Aché Laboratórios

Marinomed Biotech Aché Laboratórios Pharmaceutical R&D Marinosolv Technology Latin America Pharmaceutical Market
BRIEF

published on 04/25/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG annonce une nouvelle collaboration en R&D avec Aché Laboratórios

Marinomed Biotech Laboratoires Aché R&D Pharmaceutique Technologie Marinosolv Marché Pharmaceutique D'Amérique Latine
PRESS RELEASE

published on 04/25/2024 at 07:45, 1 year 10 months ago

Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
Marinomed Biotech AG announces R&D collaboration with Aché Laboratórios, applying Marinosolv technology to develop pharmaceutical products for Latin America

Pharmaceutical Products Marinomed Biotech AG Aché Laboratórios Marinosolv Technology R&D Collaboration
BRIEF

published on 04/16/2024 at 07:50, 1 year 11 months ago

Marinomed Biotech AG Reports Financial Results for 2023 and Development Progress

Biotechnology Marinomed Biotech AG Carragelose Financial Results 2023 Marinosolv
BRIEF

published on 04/16/2024 at 07:50, 1 year 11 months ago

Marinomed Biotech AG publie ses résultats financiers pour 2023 et ses progrès en matière de développement

Biotechnologie Marinomed Biotech AG Résultats Financiers 2023 Carrragélose Marinsolv
PRESS RELEASE

published on 04/16/2024 at 07:45, 1 year 11 months ago

Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
Marinomed Biotech AG announces 2023 financial year results, highlighting progress with Marinosolv and Carragelose assets. Focus on achieving operating profitability and commercialization

2023 Financial Year Operating Profitability Marinomed Biotech AG Marinosolv Carragelose Assets

Accesswire

Published on 03/23/2026 at 22:40, 12 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 22 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 52 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 1 hour 34 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 8 hours 47 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 22:05, 47 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 1 hour 47 minutes ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 1 hour 47 minutes ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 1 hour 52 minutes ago

Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 1 hour 57 minutes ago

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Les Echos

Published on 03/23/2026 at 19:08, 3 hours 44 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 3 hours 44 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 4 hours 15 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 5 hours 7 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 5 hours 7 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE